Carboplatin/Paclitaxel/Pertuzumab/Trastuzumab Regimen

Preferred Label : Carboplatin/Paclitaxel/Pertuzumab/Trastuzumab Regimen;

NCIt synonyms : Carboplatin/Taxol/Herceptin/Perjeta; Carboplatin/Paclitaxel/Pertuzumab/Trastuzumab; Herceptin-Perjeta-Carboplatin-Taxol; Carboplatin-Paclitaxel-Pertuzumab-Trastuzumab;

NCIt related terms : TCHP (Paclitaxel) (trastuzumab-dttb); TCHP (Paclitaxel) (trastuzumab-herw); TCHP (Paclitaxel); TCHP (Paclitaxel) (trastuzumab-anns); TCHP (Paclitaxel) (trastuzumab-dkst); TCHP (Paclitaxel) (trastuzumab-zerc); TCHP (Paclitaxel) (trastuzumab-pkrb); TCHP (Paclitaxel) (trastuzumab-qyyp);

NCIt definition : A regimen consisting of carboplatin, paclitaxel, pertuzumab and trastuzumab that may be used as a treatment for breast cancer.;

NCI Metathesaurus CUI : CL1926256;

Codes from synonyms : 128928; 129219; 128831; 129316; 129025; 129413; 54227; 129122;

Details

Origin ID

C203954;

UMLS CUI

C5910087;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Carboplatin [NCIt concept]
- Paclitaxel [NCIt concept]
- Pertuzumab [NCIt concept]
- Trastuzumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients